Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
文献类型：期刊论文
| 作者 | Zhang, Haijun1,2; Wang, Xiangfei2; Deng, Wei3; Wang, Shenguo1,4; Ge, Junbo2; Toft, Egon1,5 |
| 刊名 | MEDICINE
 |
| 出版日期 | 2016-09-01 |
| 卷号 | 95期号:38 |
| 关键词 | abluminal biodegradable polymer late lumen loss major adverse cardiovascular events sirolimus-eluting stent |
| 英文摘要 | Background:The biodegradable polymer drug-eluting stents (DES) were developed to improve vascular healing. However, further data and longer-term follow-up are needed to confirm safety and efficacy of these stents. This randomized clinical trial aimed to compare safety and efficacy of 2 sirolimus-eluting stents (SES): Cordimaxa novel abluminal biodegradable polymer SES and Cypher Selecta durable polymer SES, at 9 months angiographic and 5-year clinical follow-up.Methods:We randomized 402 patients with coronary artery disease to percutaneous coronary intervention with Cordimax (n = 202) or Cypher select (n = 200). Angiographic follow-up was performed at 9 months after the index procedure and clinical follow-up annually up to 5 years. The primary endpoint was angiographic in-stent late luminal loss (LLL). Secondary endpoints included angiographic restenosis rate, target vessel revascularization (TVR), and major adverse cardiac events (MACEs; defined as cardiac death, myocardial infarction, or TVR) at 5-year follow-up.Results:Cordimax was noninferior to Cypher select for in-stent LLL (0.250.47 vs 0.18 +/- 0.49mm; P = 0.587) and in-stent mean diameter stenosis (22.19 +/- 12.21% vs 19.89 +/- 10.79%; P = 0.064) at 9 months angiographic follow-up. The MACE rates were not different at 1 year (5.9% vs 4.0%, P = 0.376); however, MACE rates from 2 to 5 years were lower in the Cordimax group (6.8% vs 13.1%; P = 0.039).Conclusion:Abluminal biodegradable polymer SES is noninferior to durable polymer SES at 9-month angiographic and 1-year clinical follow-up. However, MACE rates from 2 to 5 years were less in the abluminal biodegradable polymer group. |
| 收录类别 | SCI |
| 语种 | 英语 |
| 源URL | [http://ir.iccas.ac.cn/handle/121111/35463]  |
| 专题 | 化学研究所_高分子物理与化学实验室 |
| 作者单位 | 1.Aalborg Univ, Dept Hlth Sci & Technol, Fac Med, Niels, Denmark 2.Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai, Peoples R China 3.Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China 4.Chinese Acad Sci, Inst Chem, Beijing, Peoples R China 5.Qatar Univ, Coll Med, Biomed Res Ctr, Postbox 2716, Doha 999043, Qatar |
| 推荐引用方式 GB/T 7714 | Zhang, Haijun,Wang, Xiangfei,Deng, Wei,et al. Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes[J]. MEDICINE,2016,95(38). |
| APA | Zhang, Haijun,Wang, Xiangfei,Deng, Wei,Wang, Shenguo,Ge, Junbo,&Toft, Egon.(2016).Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes.MEDICINE,95(38). |
| MLA | Zhang, Haijun,et al."Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes".MEDICINE 95.38(2016). |
入库方式： OAI收割
来源：化学研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。